What is ENT Handheld Instrument?

ENT Handheld Instruments Market By Product Type (Otology Instruments, Rhinology Instruments, And Laryngeal Instruments), By End User (Hospitals, Specialty Clinics, And Ambulatory Surgical Centers), and by geography is expected to grow at a steady CAGR forecast till 2026 owing to the increase in surgeries due to rise in prevalence of ENT disorders such as hearing loss and thryoid cancer. 

Global ENT Handheld Instruments Market is expected to grow at a CAGR of 6.36% during the forecast period from 2021 to 2026. The demand for ENT handheld instruments is primarily being boosted by increasing prevalence of hearing loss, increasing prevalence of thyroid cancer, rising number of cases of sinusitis, and rising geriatric population, all these collectively contributing in the growth of the ENT handheld instruments market during the forecast period from 2021-2026.

ENT Handheld Instruments Market Insights

The ENT handheld instruments market is witnessing a growth in product demand owing to numerous factors, one of them being the increasing number of cases of hearing loss due to different causes. As per the latest data provided by the World Health Organization, as of April 2021, near about 430 million people suffer from varying degrees of hearing loss. The factsheet further stated that by 2050, approximately 2.5 billion people are estimated to be affected with some degree of hearing loss. Ear surgeries such as eardrum repair (tympanoplasty), ear tube placement, and stapedectomy are some of the common procedures conducted in the ENT specialty for which ENT handheld instruments are extensively used. Therefore, the rising prevalence of hearing loss would result in the increase in the volume of such procedures, which being performed to restore hearing capacity in patients, which in turn driving the global ENT handheld instruments market growth during the forecast period from 2021-2026. 

Another key factor contributing in the growth of the global ENT handheld instruments market is the rising prevalence of thyroid cancer. As per the GLOBOCAN 2020 data, in 2020, nearly 586,202 new cases of thyroid cancer were diagnosed across the globe. One of the treatment methods for thyroid cancer is thyroidectomy in which the thyroid gland is either partially or fully removed. This is done with the help of various ENT handheld instruments that are employed during the procedure. Thus, the increase in the prevalence of thyroid cancer would result in the increase in the number of thryoidectomies being performed, eventually contributing in the growth of the ENT handheld instruments market during the forecast period. 

However, limited awareness regarding ENT disorders and treatments in emerging economies and the constant need for sterilizing the ENT handheld surgical instruments may be certain impeding factors to ENT handheld instruments market growth. 

In addition to the previously mentioned factors, the ENT handheld instruments market witnessed a period of temporary setback due to the imposing of the lockdown restrictions as necessary measures to contain the COVID-19 spread. One of the major steps during this was the suspension of numerous elective procedures and outpatient visits which reduced the demand for ENT handheld instruments in the market as various procedures pertaining to ENT specialty were deemed non-essential during the initial lockdown period, thereby limiting the market growth for a short time. Nevertheless, the market for ENT handheld instruments is on the period of recovery with the resumption of activities across various domains including healthcare services owing to the approval and administration of numerous COVID-19 vaccines across the globe, thereby presenting a positive future outlook for the ENT handheld instruments market during the forecast period.

For More Information @ ENT Handheld Instruments Competitive Landscape